|
1
|
Bluestone JA, Herold K and Eisenbarth G:
Genetics, pathogenesis and clinical interventions in type 1
diabetes. Nature. 464:1293–1300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Skyler JS and Ricordi C: Stopping type 1
diabetes: Attempts to prevent or cure type 1 diabetes in man.
Diabetes. 60:1–8. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu X, Yi H, Kato M, Suzuki H, Kobayashi S,
Takahashi H and Nakashima I: Differential sensitivities to
hyperbaric oxygen of lymphocyte subpopulations of normal and
autoimmune mice. Immunol Lett. 59:79–84. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kang N, Hai Y, Yang J, Liang F and Gao CJ:
Hyperbaric oxygen intervention reduces secondary spinal cord injury
in rats via regulation of HMGB1/TLR4/NF-κB signaling pathway. Int J
Clin Exp Pathol. 8:1141–1153. 2015.PubMed/NCBI
|
|
5
|
Tepić S, Petković A, Srejović I, Jeremić
N, Zivković V, Loncarević S, Bradić J, Jakovljević V and Zivkovć M:
Impact of hyperbaric oxygenation on oxidative stress in diabetic
patients. Undersea Hyperb Med. 45:9–17. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lee YS, Chio CC, Chang CP, Wang LC, Chiang
PM, Niu KC and Tsai KJ: Long course hyperbaric oxygen stimulates
neurogenesis and attenuates inflammation after ischemic stroke.
Mediators Inflamm. 2013:5129782013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thom SR, Bhopale VM, Velazquez OC,
Goldstein LJ, Thom LH and Buerk DG: Stem cell mobilization by
hyperbaric oxygen. Am J Physiol Heart Circ Physiol.
290:H1378–H1386. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Al-Waili NS, Butler GJ, Beale J, Abdullah
MS, Finkelstein M, Merrow M, Rivera R, Petrillo R, Carrey Z, Lee B
and Allen M: Influences of hyperbaric oxygen on blood pressure,
heart rate and blood glucose levels in patients with diabetes
mellitus and hypertension. Arch Med Res. 37:991–997. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stevens SL, Sorita A, Narr AJ, Claus PL,
Tescher A, Millman MP, Shields RC, Buchta WG, Haddon R and Murad
MH: Applying quality improvement methods in a hyperbaric oxygen
program: Reducing unnecessary glucose testing. Undersea Hyperb Med.
43:427–435. 2016.PubMed/NCBI
|
|
10
|
Nagatomo F, Takemura A, Roy RR, Fujino H,
Kondo H and Ishihara A: Mild hyperbaric oxygen inhibits the
growth-related decline in skeletal muscle oxidative capacity and
prevents hyperglycemia in rats with type 2 diabetes mellitus. J
Diabetes. 10:753–763. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Gu N, Nagatomo F, Fujino H, Takeda I,
Tsuda K and Ishihara A: Hyperbaric oxygen exposure improves blood
glucose level and muscle oxidative capacity in rats with type 2
diabetes. Diabetes Technol Ther. 12:125–133. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Faleo G, Fotino C, Bocca N, Molano RD,
Zahr-Akrawi E, Molina J, Villate S, Umland O, Skyler JS, Bayer AL,
et al: Prevention of autoimmune diabetes and induction of beta-cell
proliferation in NOD mice by hyperbaric oxygen therapy. Diabetes.
61:1769–1778. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Roden M and Bernroider E: Hepatic glucose
metabolism in humans-its role in health and disease. Best Pract Res
Clin Endocrinol Metab. 17:365–383. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Mani BK and Zigman JM: Ghrelin as a
survival hormone. Trends Endocrinol Metab. 28:843–854. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ge X, Yang H, Bednarek MA, Galon-Tilleman
H, Chen P, Chen M, Lichtman JS, Wang Y, Dalmas O, Yin Y, et al:
LEAP2 Is an endogenous antagonist of the ghrelin receptor. Cell
Metab. 27:461–469.e6. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Date Y, Kojima M, Hosoda H, Sawaguchi A,
Mondal MS, Suganuma T, Matsukura S, Kangawa K and Nakazato M:
Ghrelin, a novel growth hormone-releasing acylated peptide, is
synthesized in a distinct endocrine cell type in the
gastrointestinal tracts of rats and humans. Endocrinology.
141:4255–4261. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kojima M, Hosoda H, Date Y, Nakazato M,
Matsuo H and Kangawa K: Ghrelin is a growth-hormone-releasing
acylated peptide from stomach. Nature. 402:656–660. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang J, Brown MS, Liang G, Grishin NV and
Goldstein JL: Identification of the acyltransferase that
octanoylates ghrelin, an appetite-stimulating peptide hormone.
Cell. 132:387–396. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhao TJ, Liang G, Li RL, Xie X, Sleeman
MW, Murphy AJ, Valenzuela DM, Yancopoulos GD, Goldstein JL and
Brown MS: Ghrelin O-acyltransferase (GOAT) is essential for growth
hormone-mediated survival of calorie-restricted mice. Proc Natl
Acad Sci USA. 107:7467–7472. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Pereira JADS, da Silva FC and de
Moraes-Vieira PMM: The Impact of Ghrelin in Metabolic Diseases: An
Immune Perspective. J Diabetes Res. 2017:45279802017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mao Y, Tokudome T, Kishimoto I, Otani K,
Nishimura H, Yamaguchi O, Otsu K, Miyazato M and Kangawa K:
Endogenous ghrelin attenuates pressure overload-induced cardiac
hypertrophy via a cholinergic anti-inflammatory pathway.
Hypertension. 65:1238–1244. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li G, Liu J, Xia WF, Zhou CL and Lv LQ:
Protective effects of ghrelin in ventilator-induced lung injury in
rats. Int Immunopharmacol. 52:85–91. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hossienzadeh F, Babri S, Alipour MR,
Ebrahimi H and Mohaddes G: Effect of ghrelin on brain edema induced
by acute and chronic systemic hypoxia. Neuroscience Lett.
534:47–51. 2013. View Article : Google Scholar
|
|
24
|
Mohaddes G, Abdolalizadeh J, Babri S,
Abedini N and Hossienzadeh F: The anti-edematous effect of ghrelin
in brain hypoxia is associated with decreasing expression of
vascular endothelial growth factor. J Mol Neurosci. 56:273–277.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Heppner KM and Tong J: Mechanisms in
endocrinology: Regulation of glucose metabolism by the ghrelin
system: Multiple players and multiple actions. Eur J Endocrinol.
171:R21–R32. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
An W, Li Y, Xu G, Zhao J, Xiang X, Ding L,
Li J, Guan Y, Wang X, Tang C, et al: Modulation of ghrelin
O-acyltransferase expression in pancreatic islets. Cell Physiol
Biochem. 26:707–716. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim SW, Her SJ, Park SJ, Kim D, Park KS,
Lee HK, Han BH, Kim MS, Shin CS and Kim SY: Ghrelin stimulates
proliferation and differentiation and inhibits apoptosis in
osteoblastic MC3T3-E1 cells. Bone. 37:359–369. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang QH, Liu Y, Wu SS, Cui RR, Yuan LQ
and Liao EY: Ghrelin inhibits the apoptosis of MC3T3-E1 cells
through ERK and AKT signaling pathway. Toxicol Appl Pharmacol.
272:591–597. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhu K, Zhang ML, Liu ST, Li XY, Zhong SM,
Li F, Xu GZ, Wang Z and Miao Y: Ghrelin attenuates retinal neuronal
autophagy and apoptosis in an experimental rat glaucoma model.
Invest Ophthalmol Vis Sci. 58:6113–6122. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hao Y, Liu C, Huang J, Gu Y, Li H, Yang Z,
Liu J, Wang W and Li R: Ghrelin protects against depleted
uranium-induced apoptosis of MC3T3-E1 cells through oxidative
stress-mediated p38-mitogen-activated protein kinase pathway.
Toxicol Appl Pharmacol. 290:116–125. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Bando M, Iwakura H, Ariyasu H, Koyama H,
Hosoda K, Adachi S, Nakao K, Kangawa K and Akamizu T:
Overexpression of intraislet ghrelin enhances β-cell proliferation
after streptozotocin-induced β-cell injury in mice. Am J Physiol
Endocrinol Metab. 305:E140–E148. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Baena-Nieto G, Lomas-Romero IM, Mateos RM,
Leal-Cosme N, Perez-Arana G, Aguilar-Diosdado M, Segundo C and
Lechuga-Sancho AM: Ghrelin mitigates β-cell mass loss during
insulitis in an animal model of autoimmune diabetes mellitus, the
BioBreeding/Worcester rat. Diabetes Metab Res Rev. 332017.doi:
10.1002/dmrr.2813.
|
|
33
|
Blanco AM, Bertucci JI, Ramesh N, Delgado
MJ, Valenciano AI and Unniappan S: Ghrelin facilitates GLUT2-,
SGLT1- and SGLT2-mediated intestinal glucose transport in goldfish
(Carassius auratus). Sci Rep. 7:450242017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fuente-Martín E, García-Cáceres C,
Argente-Arizón P, Díaz F, Granado M, Freire-Regatillo A,
Castro-González D, Ceballos ML, Frago LM, Dickson SL, et al:
Ghrelin regulates glucose and glutamate transporters in
hypothalamic astrocytes. Sci Rep. 6:236732016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li RL, Sherbet DP, Elsbernd BL, Goldstein
JL, Brown MS and Zhao TJ: Profound hypoglycemia in starved,
ghrelin-deficient mice is caused by decreased gluconeogenesis and
reversed by lactate or fatty acids. J Biol Chem. 287:17942–17950.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Zhou XY, Zhang F, Hu XT, Chen J, Tang RX,
Zheng KY and Song YJ: Depression can be prevented by astaxanthin
through inhibition of hippocampal inflammation in diabetic mice.
Brain Res. 1657:262–268. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu YN, Yang Z, Kong D, Zhang Y, Yu W and
Zha W: Metformin ameliorates testicular damage in male mice with
streptozotocin-induced type 1 diabetes through the PK2/PKR Pathway.
Oxid Med Cell Longev. 2019:56817012019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang R, Yuan J, Zhang C, Wang L, Liu Y,
Song L, Zhong W, Chen X and Dong J: Neuropeptide Y-Positive neurons
in the dorsomedial hypothalamus are involved in the anorexic effect
of angptl8. Front Mol Neurosci. 11:4512018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma L, Li P, Shi Z, Hou T, Chen X and Du J:
A prospective, randomized, controlled study of hyperbaric oxygen
therapy: Effects on healing and oxidative stress of ulcer tissue in
patients with a diabetic foot ulcer. Ostomy Wound Manage. 59:18–24.
2013.PubMed/NCBI
|
|
40
|
Veyseller B, Dogan R, Yenigun A, Aksoy F,
Tugrul S, Dogan EE and Ozturan O: Hyperbaric oxygen therapy of
olfactory dysfunction in diabetic neuropathy with type 2 diabetes
mellitus and a new definition diabetic olfactopathy. Rhinology.
54:273–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stoekenbroek RM, Santema TB, Legemate DA,
Ubbink DT, van den Brink A and Koelemay MJ: Hyperbaric oxygen for
the treatment of diabetic foot ulcers: A systematic review. Eur J
Vasc Endovasc Surg. 47:647–655. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Resanovic I and Gluvic Z: Early Effects of
hyperbaric oxygen on inducible nitric oxide synthase
activity/expression in lymphocytes of type 1 diabetes patients: A
prospective pilot study. Int J Endocrinol. 2019:23285052019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Thorens B: GLUT2, glucose sensing and
glucose homeostasis. Diabetologia. 58:221–232. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Párrizas M, Maestro MA, Boj SF, Paniagua
A, Casamitjana R, Gomis R, Rivera F and Ferrer J: Hepatic nuclear
factor 1-alpha directs nucleosomal hyperacetylation to its
tissue-specific transcriptional targets. Mol Cell Biol.
21:3234–3243. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ishii S, Kamegai J, Tamura H, Shimizu T,
Sugihara H and Oikawa S: Role of ghrelin in streptozotocin-induced
diabetic hyperphagia. Endocrinology. 143:4934–4937. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Nowak N, Hohendorff J, Solecka I, Szopa M,
Skupien J, Kiec-Wilk B, Mlynarski W and Malecki MT: Circulating
ghrelin level is higher in HNF1A-MODY and GCK-MODY than in
polygenic forms of diabetes mellitus. Endocrine. 50:643–649. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Gutierrez JA, Willency JA, Knierman MD,
Coskun T, Solenberg PJ, Perkins DR, Higgs RE and Hale JE: From
ghrelin to ghrelin's O-acyl transferase. Methods Enzymol.
514:129–146. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gahete MD, Córdoba-Chacón J, Salvatori R,
Castaño JP, Kineman RD and Luque RM: Metabolic regulation of
ghrelin O-acyl transferase (GOAT) expression in the mouse
hypothalamus, pituitary, and stomach. Mol Cell Endocrinol.
317:154–160. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Hougland JL: Ghrelin octanoylation by
ghrelin O-acyltransferase: Unique protein biochemistry underlying
metabolic signaling. Biochem Soc Trans. 47:169–178. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Adriaenssens AE, Svendsen B, Lam BY, Yeo
GS, Holst JJ, Reimann F and Gribble FM: Transcriptomic profiling of
pancreatic alpha, beta and delta cell populations identifies delta
cells as a principal target for ghrelin in mouse islets.
Diabetologia. 59:2156–2165. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Chuang JC, Sakata I, Kohno D, Perello M,
Osborne-Lawrence S, Repa JJ and Zigman JM: Ghrelin directly
stimulates glucagon secretion from pancreatic alpha-cells. Mol
Endocrinol. 25:1600–1611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Tong J, Prigeon RL, Davis HW, Bidlingmaier
M, Kahn SE, Cummings DE, Tschöp MH and D'Alessio D: Ghrelin
suppresses glucose-stimulated insulin secretion and deteriorates
glucose tolerance in healthy humans. Diabetes. 59:2145–2151. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Dezaki K, Hosoda H, Kakei M, Hashiguchi S,
Watanabe M, Kangawa K and Yada T: Endogenous ghrelin in pancreatic
islets restricts insulin release by attenuating Ca2+
signaling in beta-cells: Implication in the glycemic control in
rodents. Diabetes. 53:3142–3151. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Brial F, Lussier CR, Belleville K, Sarret
P and Boudreau F: Ghrelin inhibition restores glucose homeostasis
in hepatocyte nuclear factor-1α (MODY3)-Deficient Mice. Diabetes.
64:3314–3320. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
McFarlane MR, Brown MS, Goldstein JL and
Zhao TJ: Induced ablation of ghrelin cells in adult mice does not
decrease food intake, body weight, or response to high-fat diet.
Cell Metab. 20:54–60. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Kleinridders A, Ferris HA, Cai W and Kahn
CR: Insulin action in brain regulates systemic metabolism and brain
function. Diabetes. 63:2232–2243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Özcan B, Neggers SJ, Miller AR, Yang HC,
Lucaites V, Abribat T, Allas S, Huisman M, Visser JA, Themmen AP,
et al: Does des-acyl ghrelin improve glycemic control in obese
diabetic subjects by decreasing acylated ghrelin levels? Eur J
Endocrinol. 170:799–807. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Brereton MF, Iberl M, Shimomura K, Zhang
Q, Adriaenssens AE, Proks P, Spiliotis II, Dace W, Mattis KK,
Ramracheya R, et al: Reversible changes in pancreatic islet
structure and function produced by elevated blood glucose. Nat
Commun. 5:46392014. View Article : Google Scholar : PubMed/NCBI
|
